Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
DHR · against 24 other Healthcare companies of similar size
Ranked #18 of 25 · scores higher than 29% of peers
Bars: peers in each 10-point band of the growth score6 peers with a growth score of 40–49, including DHR · Click a bar to see the companies
A mix: stronger earnings per share growth, but weaker 3-year revenue growth than most Healthcare peers.
| Metric | DHR | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 25 reported | 4.6% | 7.3% | 25% | 33% | |
| Earnings per share growthHigher is better · 24 reported | 19.5% | 22.3% | 39% | 33% | |
| 3-year revenue growthHigher is better · 25 reported | 2.9% | 6.0% | 17% | 33% |
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 126.5B USD | 78 | 56 | |
| 2 | 155.7B USD | 73 | 64 | |
| 3 | 540.4B BRL (≈$97.3B) | 72 | 64 | |
| 3 | 97.5B USD | 72 | 67 | |
| 3 | 162.93T ARS (≈$162.9B) | 72 | 63 | |
| 14 | 108.6B USD | 55 | 66 | |
| 15 | 100.2B USD | 54 | 57 | |
| 16 | 116.9B USD | 49 | 47 | |
| 16 | 100.2B USD | 49 | 68 | |
| 18 | 161.8B USD | 47 | 50 | |
| 19 | 89.7B USD | 45 | 50 | |
| 20 | 84.5B EUR (≈$92.9B) | 44 | 51 | |
| 20 | 258.2B USD | 44 | 47 | |
| 22 | 189.3B USD | 26 | 45 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score